Raras
Buscar doenças, sintomas, genes...
Encefalite equina ocidental
ORPHA:83593CID-10 · A83.1CID-11 · 1C83DOENÇA RARA

Oryzomys couesi, também conhecido popularmente no inglês como "Coues's rice rat", que seria como "rato-do-arroz-de-Coues" no Português, é um roedor semiaquático da família Cricetidae, encontrado desde o sul do Texas, passando pelo México e América Central, até o noroeste da Colômbia. Geralmente habita ambientes úmidos, como pântanos, mas também vive em florestas mais secas e arbustais.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença viral transmitida por mosquitos, causando inflamação cerebral em humanos e cavalos. Sintomas incluem febre, dor de cabeça, confusão e convulsões, podendo levar a sequelas neurológicas graves ou morte.

Publicações científicas
486 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: A83.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico486PubMed
Últimos 10 anos128publicações
Pico202529 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Encefalite equina ocidental

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

3 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
129 papers (10 anos)
#1

Informed mutation of western equine encephalitis virus to heparan sulfate binding: Implications for rational design of alphavirus live attenuated vaccines.

PLoS pathogens2026 Feb

Encephalitogenic alphaviruses are mosquito-borne viruses that can cause fatal disease in humans and equines. Currently, there are no licensed vaccines or antiviral treatments for these infections. Western equine encephalitis virus (WEEV) is a member of this group that had not produced a human infection in over a decade. However, an outbreak of WEEV encephalitis in humans and equines was reported recently in South America, indicating a need for additional countermeasures. Blind passage approaches to generation of RNA virus live attenuated vaccines (LAVs) frequently result in acquisition of positively charged amino acid mutations that confer heparan sulfate (HS) binding and that are attenuating factors in resultant LAVs. To develop an informed approach for creation of alphavirus LAVs, we have utilized the WEEV McMillan (McM) strain as an HS weak/non-binding platform into which we have placed positively charged amino acid substitution mutations at positions in the E2 glycoprotein previously shown to confer HS-dependent infection upon other alphaviruses. This approach yielded four mutants with high efficiency HS binding and avirulence in mice, which were further subjected to yield optimization by in vitro selection of second-site mutations. Interestingly, the original mutations concomitantly increased HS interactions and reduced infection promoted by VLDLR and PCDH10 protein receptors, while the second site mutations improved infectivity mediated by VLDLR. Further, we report a newly generated 4.1Å cryo-EM reconstruction of WEEV McM strain into which we have mapped the mutations to provide an E2 glycoprotein domain-based representation of receptor binding site location.

#2

Investigation of neurotropic arboviruses in wild and domestic animals in Amazon region, 2023-2024.

Memorias do Instituto Oswaldo Cruz2026

Arboviruses represent a potential threat to global public health due to their ability to infect various vertebrate hosts and vectors, as well as their adaptability to diverse ecosystems, allowing them to expand geographically across continents. The present study aimed to describe the molecular epidemiology of encephalitic arboviruses, including Venezuelan equine encephalitis virus (VEEV), Eastern equine encephalitis virus (EEEV), Western equine encephalitis virus (WEEV), West Nile virus (WNV), Saint Louis encephalitis virus (SLEV), Toscana virus (TOSV), and Rift Valley fever virus (RVFV) in nervous tissue samples from domestic and wild animals from the Northern region of Brazil, between February 2023 and June 2024. Samples negative for rabies virus were analysed by reverse transcription real-time polymerase chain reaction (RT-qPCR) targeting Alphavirus, Orthoflavivirus and Phlebovirus species.Positive samples were subjected to viral isolation in cell culture and whole-genome sequencing using next-generation sequencing.Phylogenetic and molecular clock analyses were performed to characterise viral lineages and evolutionary relationships. Two samples tested positive for arboviruses by RT-qPCR: one SLEV sample from the state of Amazonas, which showed a low viral load, preventing virus isolation and sequencing, and one Madariaga virus (MADV) sample from the state of Pará, which could be isolated and sequenced.The isolated agent belongs to lineage III of EEEV, showing most similarity to strains from Guyana and Argentina. The present study detected two arboviruses in animals, suggesting its circulation in the study area.

#3

Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus.

Journal of virology2026 Feb 17

Venezuelan equine encephalitis virus (VEEV) is a prototypical encephalitic alphavirus. Members of the Alphavirus genus are found across the globe, transmitted by arthropod vectors, and cause significant disease burdens in humans and animals. There are currently no FDA-approved antivirals for human use against any member of the Alphavirus genus. While a vaccine exists against chikungunya virus (CHIKV), a member of the arthritogenic alphaviruses, FDA-approved vaccines are not available for other members of this genus, particularly the encephalitic alphaviruses such as VEEV, Eastern equine encephalitis virus, and Western equine encephalitis virus. 4'-Fluorouridine (4'-FlU, EIDD-2749) was recently identified as a broad-spectrum antiviral against multiple RNA viruses, including alphaviruses. 4'-FlU can potently inhibit VEEV-TC83 replication, with submicromolar potency in cell culture. However, the emergence of antiviral resistance represents a hurdle for antiviral drug development and the implementation of effective treatment strategies. Here, we have identified novel mutations in the VEEV nsP4 RNA-dependent RNA polymerase that reduce susceptibility to 4'-FlU, including P187A, Q191L, L289F, and T296I. We rebuilt each mutation in recombinant VEEV-TC83 and characterized the effects of these mutations on fitness and pathogenicity. In addition, we assessed the impact of mutations reducing sensitivity to 4'-FlU in a mouse model. Although mutations against 4'-FlU arise quickly in vitro, treatment can still alleviate severe disease and lethal encephalitis. Together, these data highlight the promising therapeutic potential of 4'-FlU for the treatment of alphavirus encephalitis.IMPORTANCEVenezuelan equine encephalitis virus (VEEV) is a mosquito-spread virus that can cause encephalitis in people and animals. There are no FDA-approved countermeasures to treat VEEV infections in humans. 4'-Fluorouridine (4'-FlU) is currently being developed to treat multiple viral infections, including VEEV. A major problem with antivirals is the appearance of virus populations that are less susceptible to treatment. In this study, we treated infected mice with 4'-FlU and measured how well the compound inhibited virus replication and prevented severe disease. In addition, we identified mutations in VEEV's polymerase that confer reduced susceptibility to 4'-FlU. We then assessed if viruses encoding for these mutations were still pathogenic. Although VEEV can develop mild resistance to 4'-FlU in vitro, administration of 4'-FlU still reduced severe disease and prevented lethality in the animals infected with viruses that possess mutations that decrease susceptibility to 4'-FlU. These results suggest that 4'-FlU has strong potential as a future treatment for alphavirus infections.

#4

Validation of prototype virus inactivation from seven virus families of pandemic potential with a novel low-cost, field-deployable RNA extraction and storage method.

Journal of virological methods2026 Feb

The Centers for Research in Emerging Infectious Diseases (CREID) was established to enhance pandemic preparedness by studying emerging/reemerging pathogens, especially in resource-limited regions. To overcome infrastructure challenges, a low-cost, field-deployable method for extracting total nucleic acids is essential, eliminating reliance on expensive equipment, power, and cold chain systems used in traditional extraction techniques. To address this challenge, we developed an RNA extraction and storage method (RNAES) that meets these criteria. Herein, we report RNAES inactivation efficacy against nine prototype viruses (Middle Eastern respiratory syndrome coronavirus, Japanese encephalitis virus, West Nile virus, Hantaan virus, measles virus, Heartland virus, enterovirus A71, chikungunya virus, and Western equine encephalitis virus) representing seven pandemic potential virus families. We compare the RNAES method to the Qiagen QIAamp kit across various viral loads and field sample types. The presence of infectious virus in RNA samples was quantified using plaque assays. Successful inactivation of viruses was demonstrated for six enveloped virus families spiked into matrices routinely collected at field sites. The seventh family tested (Picornaviridae) was not completely inactivated, likely due to non-enveloped viruses being differentially susceptible to the lysis chemistry of the RNAES kit. The commercial comparator inactivated all viruses tested. Specialized biosafety facilities, specific detailed permits, and comprehensive logistics are required to ensure safety when handling and shipping potentially infectious samples. Inactivating pathogens at the point of collection reduces risks and simplifies sample transfer for critical outbreak research. Confidently ensuring that an isolated nucleic acid sample is non-infectious using RNAES will enable safer, and more efficient downstream analysis.

#5

Structural insights into VLDLR recognition by western equine encephalitis virus.

Nature communications2025 Dec 06

Western equine encephalitis virus (WEEV), a group of encephalitic alphaviruses that cause severe diseases in humans and equids, historically used the very-low-density lipoprotein receptor (VLDLR) as a receptor during infection. However, current epidemic strains no longer use VLDLR as a receptor. In this study, we identify that LA1, LA2, LA3, and LA5 of VLDLR can directly interact with WEEV. Using cryo-electron microscopy, we investigate the structures of complexes formed between WEEV and VLDLR-LBD or other VLDLR fragments. Our findings show that LA1 and LA2 insert into a cleft formed by two adjacent E2-E1 heterodimers within a single trimeric spike, while LA3 and LA5 interact with the DIII region of WEEV E1. Among VLDLR concatemers, the LA1-5 exhibits the strongest binding affinity for WEEV. Additionally, we find that a single polymorphism in the E2 glycoprotein determines WEEV's receptor tropism. Mutations E2E181K or E2E81K in the nonpathogenic strain Imperial-181 enhanced its ability to enter via VLDLR. These results enhance our understanding of alphavirus receptor recognition and receptor usage shifts, providing insights for the development of antiviral therapies.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC257 artigos no totalmostrando 127

2026

Investigation of neurotropic arboviruses in wild and domestic animals in Amazon region, 2023-2024.

Memorias do Instituto Oswaldo Cruz
2026

Informed mutation of western equine encephalitis virus to heparan sulfate binding: Implications for rational design of alphavirus live attenuated vaccines.

PLoS pathogens
2026

Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus.

Journal of virology
2025

Structural insights into VLDLR recognition by western equine encephalitis virus.

Nature communications
2025

Western equine encephalitis virus: A comprehensive review of epidemics, transmission, hosts, and strategies for mitigation.

Virulence
2026

Validation of prototype virus inactivation from seven virus families of pandemic potential with a novel low-cost, field-deployable RNA extraction and storage method.

Journal of virological methods
2025

Syndromic approach for rapid detection and differentiation of human pathogenic alphaviruses.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
2025

Development Rate of the Larvae of the Mosquito Aedes albifasciatus: A Mathematical Model as Decision Tool.

Neotropical entomology
2025

Meteorological Effects on the Abundance of West Nile Virus Mosquito Vectors in Two Communities Located on the Texas-Mexico Border in the Northern Chihuahuan Desert.

Vector borne and zoonotic diseases (Larchmont, N.Y.)
2025

An alphavirus vaccine development utilizing RNA replication-defective strategy.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

Development of in vitro and in vivo neutralization assays for New World alphaviruses based on the VSV pseudovirus system.

Emerging microbes &amp; infections
2025

Chimeric Vesicular Stomatitis Virus Bearing Western Equine Encephalitis Virus Envelope Proteins E2-E1 Is a Suitable Surrogate for Western Equine Encephalitis Virus in a Plaque Reduction Neutralization Test.

Viruses
2025

Ultra-fast, palm-sized platform for visual point-of-care virus detection using convective PCR with gold nanoparticle probes.

Mikrochimica acta
2025

Structural basis for engagement of Western Equine Encephalitis Virus with the PCDH10 receptor.

Nature communications
2025

Broad spectrum antiviral BDGR-164 provides protection against lethal neurotropic alphavirus infection in mice.

Antiviral research
2025

Machine learning identifies genes linked to neurological disorders induced by equine encephalitis viruses, traumatic brain injuries, and organophosphorus nerve agents.

Frontiers in computational neuroscience
2025

Structural basis for the recognition of two different types of receptors by Western equine encephalitis virus.

Cell reports
2025

Decoding WEEV's host adaptation.

Cell host &amp; microbe
2025

The impact of temperature and insect-specific viruses on the transmission of alphaviruses by Aedes japonicus japonicus.

Microbiology spectrum
2024

Atypical complication of western equine encephalitis: central hypoventilation syndrome.

Colombia medica (Cali, Colombia)
2024

Diagnosis and genomic characterization of the largest western equine encephalitis virus outbreak in Uruguay during 2023-2024.

Npj viruses
2025

Molecular basis for shifted receptor recognition by an encephalitic arbovirus.

Cell
2025

Structural basis for plasticity in receptor engagement by an encephalitic alphavirus.

Cell
2025

Low capacity for molecular detection of Alphaviruses other than Chikungunya virus in 23 European laboratories, March 2022.

PloS one
2025

Neuropathogenesis of Encephalitic Alphaviruses in Non-Human Primate and Mouse Models of Infection.

Pathogens (Basel, Switzerland)
2025

Host-feeding behavior of mosquitoes (Diptera: Culicidae) in North Dakota, 2003 to 2006.

Journal of medical entomology
2025

The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in mice.

Journal of virology
2025

Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches.

Virology journal
2025

nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in Mice.

ACS infectious diseases
2024

Neurological manifestations of encephalitic alphaviruses, traumatic brain injuries, and organophosphorus nerve agent exposure.

Frontiers in neuroscience
2025

Effects of climate change on the occurrence and distribution of Western equine encephalitis virus in South America.

Public health
2024

[Western equine encephalitis: Brainstem involvement and clinical manifestations].

Medicina
2025

Equine Encephalomyelitis Outbreak, Uruguay, 2023-2024.

Emerging infectious diseases
2024

Outbreak of Western Equine Encephalitis Virus Infection Associated with Neurological Disease in Horses Following a Nearly 40-Year Intermission Period in Argentina.

Viruses
2025

Unveiling the Threat: Battling the Resurgence of Western Equine Encephalitis (WEE).

Infectious disorders drug targets
2024

The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses.

Cell reports
2024

PCDH10 is a neuronal receptor for western equine encephalitis virus.

Cell research
2025

Western equine encephalitis: a pediatric case report.

Archivos argentinos de pediatria
2024

Molecular Epidemiology of Western Equine Encephalitis Virus, South America, 2023-2024.

Emerging infectious diseases
2025

Western equine encephalitis, a report of two cases in pediatric patients.

Archivos argentinos de pediatria
2024

Shifts in receptors during submergence of an encephalitic arbovirus.

Nature
2024

An improved alphaviruses-specific RT-qPCR facilitates monitoring and prevention of alphaviruses.

Journal of medical virology
2024

Syrian Hamsters Model Does Not Reflect Human-like Disease after Aerosol Exposure to Encephalitic Alphaviruses.

Methods and protocols
2024

Molecular epidemiology of Western equine encephalitis virus in Brazil, 2023-2024.

medRxiv : the preprint server for health sciences
2024

Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.

Vaccine
2024

[Preparation of mouse monoclonal antibodies against the ectodomain of Western equine encephalitis virus E2 (E2ecto) protein].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
2024

The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses.

Nature communications
2023

Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8.

Cell
2023

N4 -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness.

bioRxiv : the preprint server for biology
2023

Isolation of Flaviviruses and Alphaviruses with Encephalitogenic Potential Diagnosed by Evandro Chagas Institute (Pará, Brazil) in the Period of 1954-2022: Six Decades of Discoveries.

Viruses
2023

Sequelae and Animal Modeling of Encephalitic Alphavirus Infections.

Viruses
2022

In Vitro and In Vivo Phenotypes of Venezuelan, Eastern and Western Equine Encephalitis Viruses Derived from cDNA Clones of Human Isolates.

Viruses
2023

First comprehensive report of the resistance of Culex quinquefasciatus Say (Diptera: Culicidae) to commonly used insecticides in Riyadh, Saudi Arabia.

Heliyon
2023

Activity, Template Preference, and Compatibility of Components of RNA Replicase of Eastern Equine Encephalitis Virus.

Journal of virology
2022

Understanding host responses to equine encephalitis virus infection: implications for therapeutic development.

Expert review of anti-infective therapy
2022

Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model.

Viruses
2022

Identification of salivary gland escape barriers to western equine encephalitis virus in the natural vector, Culex tarsalis.

PloS one
2022

Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods.

Viruses
2021

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.

Viruses
2021

External quality assessment of molecular testing of 9 viral encephalitis-related viruses in China.

Virus research
2022

Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.

Virology
2021

Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.

Experimental neurology
2021

Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.

Cell
2021

Seroprevalence of arboviruses in Ecuador: Implications for improved surveillance.

Biomedica : revista del Instituto Nacional de Salud
2021

Western equine encephalitis virus virus-like particles from an insect cell-baculovirus system elicit the strong immune responses in mice.

Biotechnology journal
2021

Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore.

Bioorganic &amp; medicinal chemistry letters
2021

Serological evidence of Eastern equine encephalitis circulation in equids in Pará state, Brazil.

Brazilian journal of veterinary medicine
2021

A Tale of 20 Alphaviruses; Inter-species Diversity and Conserved Interactions Between Viral Non-structural Protein 3 and Stress Granule Proteins.

Frontiers in cell and developmental biology
2021

Beat the heat: Culex quinquefasciatus regulates its body temperature during blood feeding.

Journal of thermal biology
2021

Stabilization of a Broadly Neutralizing Anti-Chikungunya Virus Single Domain Antibody.

Frontiers in medicine
2020

A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.

Frontiers in immunology
2020

First Record of Mosquito-Borne Kyzylagach Virus in Central Europe.

Viruses
2020

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity.

Frontiers in immunology
2020

Transmission of West Nile and five other temperate mosquito-borne viruses peaks at temperatures between 23°C and 26°C.

eLife
2020

Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates.

Antiviral research
2020

Immunopathogenesis of alphaviruses.

Advances in virus research
2021

Impact of alphavirus 3'UTR plasticity on mosquito transmission.

Seminars in cell &amp; developmental biology
2020

Serosurvey of Eastern, Western, and Venezuelan Equine Encephalitis Viruses in Wild Boars (Sus scrofa), Hunting Dogs, and Hunters of Brazil.

Vector borne and zoonotic diseases (Larchmont, N.Y.)
2020

Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.

Vaccines
2020

How virus size and attachment parameters affect the temperature sensitivity of virus binding to host cells: Predictions of a thermodynamic model for arboviruses and HIV.

Microbial risk analysis
2019

Towards a thermodynamic mechanistic model for the effect of temperature on arthropod vector competence for transmission of arboviruses.

Microbial risk analysis
2020

Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry.

mBio
2020

"Submergence" of Western equine encephalitis virus: Evidence of positive selection argues against genetic drift and fitness reductions.

PLoS pathogens
2020

Complete Coding Sequence of Western Equine Encephalitis Virus Strain Fleming, Isolated from a Human Case.

Microbiology resource announcements
2020

The Capsid Protein of Semliki Forest Virus Antagonizes RNA Interference in Mammalian Cells.

Journal of virology
2020

Agua Salud alphavirus defines a novel lineage of insect-specific alphaviruses discovered in the New World.

The Journal of general virology
2019

Cooperativity between the 3' untranslated region microRNA binding sites is critical for the virulence of eastern equine encephalitis virus.

PLoS pathogens
2018

Selection of Single-Domain Antibodies towards Western Equine Encephalitis Virus.

Antibodies (Basel, Switzerland)
2019

Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation.

NPJ Parkinson's disease
2019

The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection.

Antiviral research
2020

SEROLOGICAL SURVEY FOR SELECT INFECTIOUS AGENTS IN WILD MAGELLANIC PENGUINS (SPHENISCUS MAGELLANICUS) IN ARGENTINA, 1994-2008.

Journal of wildlife diseases
2019

New World alphavirus protein interactomes from a therapeutic perspective.

Antiviral research
2018

Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development.

PloS one
2019

Continued Evidence of Decline in the Enzootic Activity of Western Equine Encephalitis Virus in Colorado.

Journal of medical entomology
2018

Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health.

The open virology journal
2018

Genetic control of alphavirus pathogenesis.

Mammalian genome : official journal of the International Mammalian Genome Society
2018

Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.

Antiviral research
2018

Wing morphometrics of Aedes (Ochlerotatus) albifasciatus (Macquart, 1838) (Diptera: Culicidae) from different climatic regions of Argentina.

Parasites &amp; vectors
2018

Genomic Characterization and Seroprevalence Studies on Alphaviruses in Uruguay.

The American journal of tropical medicine and hygiene
2018

Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus.

Viruses
2018

Serological evidence of widespread exposure of Grenada fruit bats to chikungunya virus.

Zoonoses and public health
2017

Host-Feeding Patterns of Culex stigmatosoma (Diptera: Culicidae) in Southern California.

Journal of medical entomology
2017

Venezuelan Equine Encephalitis Virus Capsid-The Clever Caper.

Viruses
2017

Susceptibility and Lethality of Western Equine Encephalitis Virus in Balb/c Mice When Infected by the Aerosol Route.

Viruses
2017

The role of birds in arboviral disease surveillance in Harris County and the City of Houston, Texas.

U.S. Army Medical Department journal
2017

Potential Sympatric Vectors and Mammalian Hosts of Venezuelan Equine Encephalitis Virus in Southern Mexico.

Journal of wildlife diseases
2017

Discovery of a novel alphavirus related to Eilat virus.

The Journal of general virology
2017

Exploring genetic variation in haplotypes of the filariasis vector Culex quinquefasciatus (Diptera: Culicidae) through DNA barcoding.

Acta tropica
2016

A Quantitative Real-Time RT-PCR Assay for the Detection of Venezuelan equine encephalitis virus Utilizing a Universal Alphavirus Control RNA.

BioMed research international
2016

Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.

PLoS neglected tropical diseases
2016

Notice to Readers: Final 2015 Reports of Nationally Notifiable Infectious Diseases and Conditions.

MMWR. Morbidity and mortality weekly report
2017

Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Journal of virology
2016

Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.

Virology
2016

Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation.

Computational biology and chemistry
2016

Hospitalized Children With Encephalitis in the United States: A Pediatric Health Information System Database Study.

Pediatric neurology
2016

Avian Encephalomyelitis in Layer Pullets Associated with Vaccination.

Avian diseases
2016

Culex Tarsalis Mosquitoes as Vectors of Highlands J Virus.

Vector borne and zoonotic diseases (Larchmont, N.Y.)
2016

Virus-specific thermostability and heat inactivation profiles of alphaviruses.

Journal of virological methods
2016

Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Journal of virology
2016

Molecular determinants of alphavirus neuropathogenesis in mice.

The Journal of general virology
2016

Surveillance for Western Equine Encephalitis, St. Louis Encephalitis, and West Nile Viruses Using Reverse Transcription Loop-Mediated Isothermal Amplification.

PloS one
2015

Occurrence of antibodies anti -Toxoplasma gondii, Neospora caninum and Leptospira interrogans in a captive deer herd in Southern Brazil.

Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria
2015

Multiplex qRT-PCR for the Detection of Western Equine Encephalomyelitis, St. Louis Encephalitis, and West Nile Viral RNA in Mosquito Pools (Diptera: Culicidae).

Journal of medical entomology
2015

[Establishment of a One-Step Real-Time RT-PCR Method for the Detection of Venezuelan Equine Encephalitis Virus].

Bing du xue bao = Chinese journal of virology
2015

Human and animal health on three continents--a biography of the early life of Karl Friedrich Meyer (1884-1974).

Pathogens and disease
2015

The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.

PloS one
2015

The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products.

Journal of biomolecular screening
Ver todos os 257 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Encefalite equina ocidental.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Encefalite equina ocidental

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Informed mutation of western equine encephalitis virus to heparan sulfate binding: Implications for rational design of alphavirus live attenuated vaccines.
    PLoS pathogens· 2026· PMID 41662398mais citado
  2. Investigation of neurotropic arboviruses in wild and domestic animals in Amazon region, 2023-2024.
    Memorias do Instituto Oswaldo Cruz· 2026· PMID 41849539mais citado
  3. Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus.
    Journal of virology· 2026· PMID 41537597mais citado
  4. Validation of prototype virus inactivation from seven virus families of pandemic potential with a novel low-cost, field-deployable RNA extraction and storage method.
    Journal of virological methods· 2026· PMID 41161420mais citado
  5. Structural insights into VLDLR recognition by western equine encephalitis virus.
    Nature communications· 2025· PMID 41353198mais citado
  6. Western equine encephalitis virus: A comprehensive review of epidemics, transmission, hosts, and strategies for mitigation.
    Virulence· 2025· PMID 41178425recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:83593(Orphanet)
  2. MONDO:0019380(MONDO)
  3. GARD:7888(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q18553953(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Encefalite equina ocidental
Compêndio · Raras BR

Encefalite equina ocidental

ORPHA:83593 · MONDO:0019380
Prevalência
1-9 / 1 000 000
Herança
Not applicable
CID-10
A83.1 · Encefalite eqüina ocidental
CID-11
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C0153064
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades